000 01559 a2200361 4500
005 20250513104750.0
264 0 _c19961220
008 199612s 0 0 eng d
022 _a0037-9727
024 7 _a10.3181/00379727-213-44051
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGaidano, G
245 0 0 _aAIDS-related Burkitt's-type lymphomas are a target for lymphokine-activated killers induced by interleukin-2 and prolactin.
_h[electronic resource]
260 _bProceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
_cNov 1996
300 _a196-205 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aBurkitt Lymphoma
_ximmunology
650 0 4 _aCytotoxicity, Immunologic
650 0 4 _aHumans
650 0 4 _aInterleukin-2
_xpharmacology
650 0 4 _aKiller Cells, Lymphokine-Activated
_ximmunology
650 0 4 _aKiller Cells, Natural
_ximmunology
650 0 4 _aLymphoma, AIDS-Related
_ximmunology
650 0 4 _aProlactin
_xpharmacology
650 0 4 _aRecombinant Proteins
_xpharmacology
650 0 4 _aTumor Cells, Cultured
700 1 _aContarini, M
700 1 _aPastore, C
700 1 _aSaglio, G
700 1 _aMatera, L
773 0 _tProceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
_gvol. 213
_gno. 2
_gp. 196-205
856 4 0 _uhttps://doi.org/10.3181/00379727-213-44051
_zAvailable from publisher's website
999 _c8924080
_d8924080